Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.57 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.57 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.57 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.57 |
| ▸ | POLA1 | P09884 | 1/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.47 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.41 |
| ▸ | CDA | P32320 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233416 | 1.00 | SLC29A1 (0.57) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| SCHEMBL1763360 | 1.00 | SLC29A1 (0.57) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| SCHEMBL7876363 | 1.00 | SLC29A1 (0.57) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| Hydrochloric Acid SCHEMBL29938288 | 0.99 | SLC29A1 (0.56) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| Phosphoric Acid SCHEMBL20769291 | 0.95 | SLC28A1 (0.53) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| Phosphoric Acid SCHEMBL4575893 | 0.95 | SLC28A1 (0.53) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| Phosphoramidic Acid SCHEMBL17439381 | 0.93 | SLC29A1 (0.51) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| SCHEMBL12170413 | 0.88 | SLC29A1 (0.59) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| SCHEMBL6758716 | 0.88 | SLC29A1 (0.59) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 | |
| SCHEMBL94634 | 0.88 | SLC29A1 (0.59) | SLC29A1SLC28A1SLC28A2SLC28A3POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013048952-A1 | METHODS AND COMPOSITIONS FOR DETECTING INFECTIONS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2013-04-04 | — | — | WO | claimed |
| WO-2013048952-A1 | METHODS AND COMPOSITIONS FOR DETECTING INFECTIONS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2013-04-04 | — | — | WO | disclosed |
| US-5618803-A | TO BRAIN | UNIVERSITY OF FLORIDA (US) | 1997-04-08 | — | — | US | disclosed |
| EP-0539493-B1 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | BODOR NICHOLAS S (US) | 1997-03-26 | — | — | EP | disclosed |
| EP-0577725-A4 | TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES | UNIV FLORIDA (US) | 1996-04-17 | — | — | EP | disclosed |
| US-5413996-A | Delivery of steroid sex hormone or antiinflammatory steroid to the brain | UNIVERSITY OF FLORIDA (US) | 1995-05-09 | — | — | US | disclosed |
| EP-0577725-A1 | TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1994-01-12 | — | — | EP | disclosed |
| EP-0539493-A4 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | — | 1993-06-02 | — | — | EP | disclosed |
| EP-0539493-A1 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES. | BODOR NICHOLAS S (US) | 1993-05-05 | — | — | EP | disclosed |
| US-5177064-A | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1993-01-05 | — | — | US | disclosed |
| WO-1992017185-A1 | TARGETED DRUG DELIVERY VIA MIXED PHOSPHATE DERIVATIVES | UNIVERSITY OF FLORIDA (US) | 1992-10-15 | — | — | WO | disclosed |
| WO-1992000988-A1 | TARGETED DRUG DELIVERY VIA PHOSPHONATE DERIVATIVES | BODOR NICHOLAS S (US) | 1992-01-23 | — | — | WO | disclosed |